2章 急性骨髄性白血病 AML

2 . AML.. CQ 1 AML . CQ 2 AML . CQ 3 AML . CQ 4 AML . CQ 5 AML . CQ 6 APL . CQ 7 Down AML . 38 AML.. AML . AML. CQ1. Down AML. APL. AML Down APL . CQ7 CQ6.. t 8;21 . inv 16 .. CQ2, 3 CQ2, 3 CQ2 4. ATRA SCT.. CQ . 39.. acute myeloid leukemia AML 180. 2.. 10 . acute promyelocytic leukemia APL 25 Down AML. myeloid leukemia associated with Down syndrome ML-DS de novo AML 3 . FAB . WHO de novo AML . 70 . SCT AML . SCT APL ATRA . 90 ATO . ML-DS Down . de novo AML . APL . 40 AML.. CQ1. AML .. AML heterogeneous AML . FAB .. WHO .. 1. FAB . WHO . 1A.. May-Giemsa Wright-Giemsa . FAB .. AML . acute lymphoblastic leukemia ALL .. acute promyelocytic leukemia APL AML .. HLA-DR . CD34 CD15 AML . PML-RARA .. WHO . t 8;21 . q22;q22 /RUNX1-RUNX1T1, inv 16 . or 16;16 . t ;. q22 . /CEFB-MYH11 Monosomy 7, 5q-, 16;21 . t p11;q22 /FUS- ERG, 9;22 . t q34; /BCR-ABL, FLT3-ITD AML.

1．acute myeloid leukemia OR acute myelogenous leukemia OR acute myeloblastic leukemia 12,248件 3．children OR childhood OR pediatric 806件 文献 1） Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML : analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research

Loading..

Tags:

  Acute, Leukemia

Information

Related search queries